Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine

J Microbiol Immunol Infect. 2020 Aug;53(4):660-662. doi: 10.1016/j.jmii.2020.06.013. Epub 2020 Jun 30.
No abstract available

Keywords: Complement component 5 (C5) inhibitor; Gonorrhea; Humanized monoclonal antibody; Innate immunity; Sexually transmitted infection.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bacteremia / diagnosis*
  • Bacteremia / pathology
  • Complement Inactivating Agents / adverse effects*
  • Drug Resistance, Multiple, Bacterial
  • Gonorrhea / diagnosis*
  • Gonorrhea / pathology
  • Hemoglobinuria, Paroxysmal / drug therapy*
  • Humans
  • Male
  • Meningococcal Vaccines / adverse effects*
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects
  • Neisseria gonorrhoeae / isolation & purification*
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • Meningococcal Vaccines
  • ravulizumab